FGFR-IN-10 is an orally active inhibitor of fibroblast growth factor receptors (FGFRs) and cytochrome P450 (CYP) enzymes; it inhibits both wild-type and V564F mutant FGFR2 with IC50 values of 104.1 nM and 43.6 nM, respectively, and also inhibits CYP isoforms including CYP2C9 (IC50 = 3.33 μM), CYP2C19 (IC50 = 18.75 μM), CYP2D6 (IC50 = 4.34 μM), and CYP3A4 (IC50 = 0.69 μM).